Please ensure Javascript is enabled for purposes of website accessibility

MCAS and the Gut: Could Mast Cell Activation Be Behind Your ‘Mystery’ Digestive Symptoms?

By Jeffrey Mark, M.D., The Real Gut Doctor®
Medically reviewed by Frances Mark, Pharm.D.
Updated August 2026


Quick Answer: What Does MCAS Have to Do With the Gut?

A lot.

Mast cells are immune cells found throughout the body, including in large numbers along the gastrointestinal tract, where they sit at the interface between your immune system and the outside world.

When mast cells release mediators such as histamine, prostaglandins and leukotrienes inappropriately, they can affect intestinal secretion, sensation and other gastrointestinal functions.

For some people with Mast Cell Activation Syndrome, or MCAS, the gut becomes one of the most noticeable places where the problem shows up.

Symptoms can include:

  • Abdominal cramping
  • Diarrhea
  • Nausea
  • Vomiting
  • Food-associated symptoms
  • Bloating or digestive discomfort

But here is where things become complicated:

MCAS can look like IBS.
IBS can look like MCAS.
SIBO can coexist with either.
Food intolerance can muddy the picture further.

And simply finding mast cells in an intestinal biopsy does not prove someone has MCAS.

The challenge is determining which biological process is actually driving the symptoms.

That is precisely why patients with complex, gut-dominant symptoms often need more than another antihistamine, restrictive diet or standard stool test.

They need someone who understands both the gastrointestinal system and the larger immune-metabolic picture.


The Patient Who Seems to React to Everything

Woman noticing a flushed rash on her forearm at a meal

Perhaps this sounds familiar.

You eat leftovers and suddenly feel flushed.

Wine gives you a headache and racing heart.

Fermented foods make you feel awful.

A restaurant meal leaves you bloated for two days.

Your stomach hurts after foods you ate without difficulty five years ago.

Then come the seemingly unrelated symptoms:

Brain fog.

Itching.

Fatigue.

A pounding heart.

Lightheadedness.

Congestion.

Sleep disruption.

Maybe you have already been diagnosed with:

IBS.

Then SIBO.

Then “leaky gut.”

Then histamine intolerance.

Then food sensitivities.

You eliminate gluten.

Then dairy.

Then eggs.

Then fermented foods.

Then high-histamine foods.

Then FODMAPs.

Pretty soon there are seven things left in the refrigerator, and four of them are zucchini.

Yet you still do not feel well.

At that point the most useful question may no longer be:

“What food am I reacting to?”

It may be:

“Why is my body reacting so strongly in the first place?”

Mast-cell biology may be one part of that answer.


What Is Mast Cell Activation Syndrome?

Mast cells are highly specialized immune cells.

They are supposed to protect you.

When appropriately activated, they release chemical messengers that help the body respond to threats.

These mediators include:

  • Histamine
  • Tryptase
  • Prostaglandins
  • Leukotrienes
  • Cytokines
  • Other signaling molecules

The problem develops when mast-cell mediators are released inappropriately or excessively.

Mast Cell Activation Syndrome describes a disorder involving recurrent episodes of systemic mast-cell activation.

Importantly, MCAS is not synonymous with:

  • Having allergies
  • Having high histamine
  • Having IBS
  • Having many food intolerances
  • Having increased mast cells on a gastrointestinal biopsy
  • Having systemic mastocytosis

Those are very different things.

Current AAAAI criteria emphasize recurrent symptoms compatible with mast-cell activation, objective evidence that mast-cell mediators rise during episodes, and improvement with treatments that block mast-cell mediators or activation.

That distinction matters because MCAS has become popular online.

And when a diagnosis becomes popular, there is a danger that every unexplained symptom gets placed underneath the same umbrella.

Good medicine works in the opposite direction.

We first ask:

Does this actually behave like mast-cell activation?

Then:

What else could explain it?


Why Can MCAS Cause So Many Gut Symptoms?

The gastrointestinal tract is one of the body’s largest interfaces with the external environment.

Every day your gut encounters:

  • Food proteins
  • Bacteria
  • Microbial metabolites
  • Medications
  • Chemicals
  • Allergens
  • Toxins
  • Viruses and other microorganisms

Mast cells live strategically within this environment.

They communicate with immune cells, nerves, blood vessels and the intestinal lining.

When mast-cell mediators are released, the effects can therefore be felt quickly.

A 2024 review focused specifically on MCAS and gut dysfunction noted that gastrointestinal manifestations can resemble IBS, with abdominal cramping and loose stools particularly prominent.

That is one reason MCAS can hide in plain sight.

The patient may be told:

You just have IBS.

But IBS describes a clinical syndrome.

It does not necessarily tell us every biological mechanism contributing to that person’s symptoms.


The Mast Cell–Gut Connection

This relationship appears to work in more than one direction.

1. Mast Cells Can Influence Gut Sensitivity

Mast cells communicate closely with the nervous system.

When mediators are released near gastrointestinal nerves, they may contribute to increased visceral sensitivity.

That means a normal amount of intestinal stretching, gas or digestion may be experienced as disproportionately uncomfortable.

For the patient, it feels like:

“My stomach reacts to everything.”

The problem may not necessarily be 30 individual foods.

The system processing those foods may have become unusually reactive.

2. Mast Cells Can Affect the Intestinal Barrier

Research increasingly implicates excessive mast-cell activation in intestinal barrier dysfunction.

A 2025 review of mast cells in digestive disease described their role in regulating the intestinal barrier and how excessive activation may contribute to abnormal permeability and gastrointestinal inflammation.

But this requires nuance.

It does not mean:

Leaky gut causes MCAS.

Nor does it mean:

Heal your leaky gut and MCAS disappears.

Those conclusions go beyond current evidence.

The better interpretation is that the intestinal barrier, immune signaling, microbiome and mast cells exist in a highly interconnected ecosystem.

When one part becomes disturbed, others may be affected.

3. Mast Cell Symptoms Can Mimic IBS

This is one of the most clinically relevant overlaps.

Abdominal discomfort.

Cramping.

Loose stools.

Food-triggered symptoms.

Nausea.

These are hardly exclusive to MCAS.

They can occur with IBS, celiac disease, inflammatory bowel disease, carbohydrate intolerance, infections and many other conditions.

A gastroenterologist evaluating suspected MCAS therefore has two jobs:

Determine whether mast-cell activation is plausible.

And equally important:

Make sure something else has not been missed.


MCAS vs IBS: How Can You Tell the Difference?

One major clue is that true systemic mast-cell activation typically does not stay confined to the gastrointestinal tract.

Current consensus-oriented criteria emphasize recurrent episodes involving multiple organ systems.

For example, a patient might experience gastrointestinal symptoms together with:

Skin

  • Flushing
  • Hives
  • Itching
  • Swelling

Cardiovascular

  • Rapid heartbeat
  • Low blood pressure
  • Fainting or near-fainting

Respiratory

  • Wheezing
  • Shortness of breath
  • Throat symptoms

Gastrointestinal

  • Cramping
  • Diarrhea
  • Nausea
  • Vomiting

The AAAAI notes that involvement of two or more organ systems during acute recurrent episodes substantially increases suspicion for systemic mast-cell activation.

In contrast, someone with chronic bloating and constipation alone should not automatically be labeled as having MCAS.

That distinction prevents both underdiagnosis and overdiagnosis.


MCAS vs Histamine Intolerance: Are They the Same Thing?

No.

They are frequently confused.

Histamine intolerance is generally used to describe symptoms thought to result from an imbalance between histamine exposure and the body’s capacity to metabolize it.

MCAS involves inappropriate activation of mast cells and release of multiple mediators.

Histamine is only one of them.

A mast cell can release:

  • Histamine
  • Tryptase
  • Prostaglandins
  • Leukotrienes
  • Cytokines
  • Other inflammatory mediators

That helps explain why some patients do not fit neatly into a simple “high histamine” model.

It is also why putting every symptomatic patient on a low-histamine diet indefinitely may not answer the real clinical question.


Can MCAS Cause SIBO?

This is where internet medicine often outruns the evidence.

We cannot currently say:

“MCAS causes SIBO.”

Nor can we confidently say:

“SIBO causes MCAS.”

But overlap can occur.

And for a patient with severe gastrointestinal symptoms, overlooking SIBO, IMO, motility dysfunction or another GI condition while attributing everything to mast cells can delay useful treatment.

A recent Mayo Clinic-associated analysis of patients with elevated gastrointestinal mucosal mast cells found SIBO in many of the patients who underwent testing. The investigators concluded that evaluation should focus on other potential explanations including inflammatory, allergic, infectious and motility disorders, as well as SIBO.

That finding does not prove causation.

It demonstrates something more clinically useful:

Complex patients often have overlapping problems.

This is one of the reasons the gut must be evaluated as an entire system.


Can a Colonoscopy or Endoscopy Diagnose MCAS?

Not by simply counting mast cells.

This may be one of the most important things you read in this article.

Mast cells normally live in gastrointestinal tissue.

There is currently no universally accepted number of mast cells per high-power field that diagnoses MCAS.

A major pathology review concluded that mast-cell quantification in non-neoplastic conditions such as MCAS remains controversial and that requests for routine counts are not supported by strong published evidence.

And the evidence has become even stronger.

A 2026 study comparing gastrointestinal biopsies from MCAS, systemic mastocytosis, inflammatory disorders and controls found that mast-cell enumeration had limited ability to diagnose MCAS.

That matters.

A pathology report saying:

“25 mast cells per high-power field”

is not automatically a diagnosis of MCAS.

Endoscopy and colonoscopy can still be extremely valuable.

Why?

Because they can help identify or rule out other diseases.

The 2024 gastroenterology review on MCAS specifically notes that endoscopy with biopsy is not used to diagnose MCAS itself, but may be important for excluding alternative gastrointestinal conditions.


MCAS Is Not the Same as Systemic Mastocytosis

This distinction is critical.

In systemic mastocytosis, abnormal clonal mast cells accumulate in tissues.

That is different from MCAS, in which the core problem is inappropriate mediator release.

Systemic mastocytosis may require evaluation involving:

  • Baseline serum tryptase
  • KIT mutation testing
  • Specialized pathology
  • Bone marrow evaluation in selected patients
  • Allergy/immunology or hematology expertise

Abnormal mast-cell aggregates, atypical morphology and markers such as CD25 can help identify systemic mastocytosis in tissue.

This is not a distinction that should be made from an internet checklist.


How Is MCAS Actually Evaluated?

Blood test vials for mast cell mediator testing

A thoughtful evaluation usually begins with the pattern, not the laboratory.

Step 1: Determine Whether the Symptoms Fit Mast-Cell Activation

We look at:

  • What happens during an episode?
  • How suddenly does it occur?
  • Which organ systems are involved?
  • What triggers it?
  • How long does it last?
  • Is it episodic or simply present every day?
  • Are gastrointestinal and non-gastrointestinal symptoms occurring together?

Timing matters enormously.

Step 2: Obtain Appropriate Mast-Cell Mediator Testing

One of the best-characterized biomarkers is serum tryptase.

The key is not simply:

“Is my tryptase outside the laboratory range?”

For episodic systemic mast-cell activation, the change from the individual’s baseline can be more informative.

A commonly used consensus threshold is an acute tryptase increase of:

Baseline tryptase × 1.2 + 2 ng/mL

often described as the 20% + 2 rule.

The sample needs to be obtained in the appropriate time window after a reaction and compared with a baseline sample.

Urinary mast-cell mediator metabolites may also contribute to evaluation in selected cases.

Testing should be interpreted in clinical context.

One isolated laboratory result should not become the entire diagnosis.

Step 3: Look for the Mimics

This is where the gastroenterology lens becomes extremely important.

Depending on symptoms, evaluation may need to consider:

  • Celiac disease
  • Inflammatory bowel disease
  • IBS
  • SIBO
  • Intestinal methanogen overgrowth
  • Food allergy
  • Food intolerance
  • Eosinophilic gastrointestinal disease
  • Motility disorders
  • Pancreatic disease
  • Bile-acid disorders
  • Medication effects
  • Infection
  • Structural gastrointestinal disease

If we diagnose MCAS without looking for these conditions, we may solve the wrong problem.

Step 4: Determine Whether a Clonal Mast-Cell Disorder Needs to Be Excluded

Some presentations require evaluation for systemic mastocytosis or another clonal mast-cell disorder.

The AAAAI notes that KIT D816V testing and, in appropriately selected patients, bone marrow evaluation can become part of that workup.

This is an area where collaboration with allergy/immunology or hematology may be appropriate.

The right specialist is not a threat to good medicine.

The right specialist is part of good medicine.


How Is MCAS Treated?

There is no one universal MCAS protocol.

Treatment is individualized according to symptoms, mediators, triggers, severity and associated conditions.

Conventional treatment can include therapies that:

  • Block H1 histamine receptors
  • Block H2 histamine receptors
  • Reduce leukotriene signaling
  • Stabilize mast cells
  • Address other mediator pathways
  • Reduce severe allergic reactivity in selected patients

Examples used in appropriate patients include H1 antihistamines, H2 blockers, leukotriene-modifying medications, cromolyn and selected other therapies. More advanced therapy may be considered under specialist supervision.

And if someone is experiencing anaphylaxis, epinephrine is first-line emergency treatment.

But medication is only part of the equation for many patients with prominent GI symptoms.

We also need to ask:

What else is happening inside the gastrointestinal system?


Why Treating Only the Histamine May Not Be Enough

Imagine a smoke detector going off repeatedly.

You can put earmuffs on.

That makes the alarm quieter.

But you still need to determine whether someone burned toast…

or whether the house is actually on fire.

Antihistamines can be extremely useful.

But if a patient also has:

  • SIBO
  • Severe constipation
  • Malnutrition from excessive dietary restriction
  • Celiac disease
  • A motility disorder
  • Another inflammatory GI condition
  • Medication-related gastrointestinal dysfunction

those problems still need attention.

This is the difference between suppressing one signal and understanding the system producing the signal.


Why The Gut Deserves Special Attention in MCAS

The gastrointestinal tract is not simply a tube that digests food.

It is an immune organ.

It is a neurological organ.

It contains a vast microbial ecosystem.

And it continuously communicates with the rest of the body.

That is why a patient may experience what appears to be a strange collection of symptoms:

Bloating after lunch.

Flushing at night.

Brain fog after a meal.

Diarrhea after certain foods.

A pounding heart.

Then three days when everything seems normal.

The symptoms can look disconnected.

Biologically, they may not be.

The challenge is discovering which connections are real.


Why The Real Gut Doctor® Is Different for Complex MCAS-Like Gut Symptoms

Many patients with suspected MCAS become trapped between specialties.

The gastroenterologist evaluates the gut.

The allergist evaluates the allergy symptoms.

Another clinician treats SIBO.

Someone else prescribes supplements.

Another practitioner orders a giant food panel.

Each person sees one piece.

But complex biology does not respect medical department boundaries.

That is where the approach at The Real Gut Doctor® can be particularly valuable.

1. Start With a Board-Certified Gastroenterologist

Jeffrey Mark, M.D. has more than three decades of clinical experience and is board-certified in gastroenterology, with additional training and certification in functional and regenerative medicine. His training includes an internal medicine residency at Northwestern and gastroenterology fellowship training at Chicago Medical School.

That matters in MCAS-like presentations.

Before assuming everything is mast-cell related, a gastrointestinal physician can ask:

What gastrointestinal disease are we missing?

That question can be just as important as:

Could this be MCAS?

2. Look Beyond the Diagnosis to the Contributing Systems

The Real Gut Doctor® approach is built around identifying underlying contributors to complex chronic symptoms rather than simply giving each symptom a separate treatment.

For the right patient, that may mean assessing:

  • Gastrointestinal function
  • Bowel motility
  • Possible microbial overgrowth
  • Nutritional status
  • Medication effects
  • Immune-mediated gastrointestinal disease
  • Diet and genuine food triggers
  • Other abnormalities suggested by the clinical history

Not everyone needs every test.

Precision means knowing which questions deserve testing.

3. Medication Expertise Matters

MCAS patients often arrive taking an impressive collection of:

  • Antihistamines
  • Acid blockers
  • Supplements
  • Mast-cell-directed compounds
  • Prescription medications

Sometimes more is not better.

Medication selection, interactions, dosing, adverse effects and unnecessary duplication matter.

That is one reason the collaborative involvement of a Doctor of Pharmacy adds another valuable layer to complex care.

The objective is not simply to add things.

Sometimes the most sophisticated intervention is knowing what not to add.

4. We Are Willing to Say When It Is Not MCAS

This is perhaps the most important distinction of all.

If your symptoms are actually being driven by:

SIBO,

celiac disease,

IBS,

a motility disorder,

true food allergy,

inflammatory disease,

or another gastrointestinal condition…

you do not benefit from being labeled with MCAS just because it is a fashionable diagnosis.

And if your clinical pattern genuinely suggests systemic mast-cell activation, appropriate allergy/immunology or hematology collaboration may be necessary.

The goal is not to prove that you have MCAS.

The goal is to find out what is actually happening.


Who Should Consider a Deeper MCAS and Gut Evaluation?

You may deserve a more comprehensive evaluation if:

  • Food seems to trigger both gastrointestinal and whole-body symptoms
  • You experience diarrhea or abdominal cramping together with flushing, hives, palpitations or lightheadedness
  • You have been told you have IBS but your symptoms extend far beyond the gut
  • You have recurrent SIBO that keeps coming back
  • Your food list keeps shrinking
  • A low-histamine diet helps somewhat but has not solved the problem
  • You have received conflicting diagnoses from multiple clinicians
  • You have been told your testing is “normal” despite significant symptoms
  • You have been diagnosed with MCAS solely from symptoms or a GI mast-cell count and want a more rigorous assessment
  • You are tired of treating each symptom as though it belongs to a different body

For these patients, the answer may not be one more supplement.

It may be a better investigation.


Frequently Asked Questions About MCAS and the Gut

Can MCAS cause bloating?

Bloating can occur in people with suspected MCAS, but it is nonspecific. IBS, SIBO, IMO, carbohydrate intolerance, constipation, motility disorders and many other gastrointestinal conditions can also cause bloating. Bloating alone does not diagnose MCAS.

Can MCAS cause diarrhea?

Yes. Diarrhea, abdominal cramping, nausea and vomiting are among the gastrointestinal manifestations most consistently associated with systemic mast-cell activation.

Can MCAS cause constipation?

Constipation is reported by some patients with complex mast-cell disorders, but it is less characteristic of the classic systemic mast-cell activation pattern than diarrhea and cramping. Constipation should prompt evaluation for motility disorders, medication effects, IBS-C, IMO and other causes rather than automatically being attributed to MCAS.

Is histamine intolerance the same as MCAS?

No. MCAS involves inappropriate mast-cell activation and release of multiple mediators. Histamine intolerance refers more narrowly to symptoms attributed to histamine exposure or handling. The two can produce overlapping symptoms but should not automatically be considered the same disorder.

Does high histamine mean I have MCAS?

No. Histamine can be influenced by several biological processes, and a single histamine measurement does not establish MCAS.

Does a normal tryptase rule out MCAS?

A normal baseline tryptase does not by itself exclude episodic mast-cell activation. When MCAS is suspected, the relationship between mediator levels during an acute episode and the person’s baseline is important.

Can a colonoscopy diagnose MCAS?

Not through mast-cell counting alone. Routine mast-cell numbers on GI biopsies have limited diagnostic utility for MCAS, according to both earlier pathology reviews and new 2026 research.

Is MCAS curable?

MCAS is heterogeneous, and promising anyone a universal “cure” or guaranteed resolution is not scientifically responsible. The clinical goal is to establish the correct diagnosis, identify treatable contributors and triggers, reduce mediator-driven symptoms and address overlapping disorders.


The Bottom Line

If eating has become unpredictable…

If your symptoms seem to jump from your gut to your skin, heart, head or respiratory system…

If you have been diagnosed with IBS, SIBO, food intolerance or histamine intolerance but still feel that something is missing…

mast-cell activation may deserve consideration.

But the answer is not to diagnose MCAS from a TikTok checklist.

It is not to assume every food reaction is histamine.

And it is not to count mast cells in a colon biopsy and declare the mystery solved.

The better question is:

What is driving this pattern in your body?

For patients whose symptoms center heavily around the gastrointestinal tract, evaluating that question through both a board-certified gastroenterology lens and a broader systems-based approach can be especially valuable.

Because sometimes the gut is where the symptoms appear.

Sometimes it is where an important part of the problem begins.

And sometimes it is where the clues have been hiding all along.


Still Being Told “Everything Looks Normal”?

If you have been bounced between specialists, eliminated half your diet, treated SIBO repeatedly, experimented with antihistamines and supplements, or been told that your symptoms are simply IBS…

you may not need another isolated treatment.

You may need someone to connect the clues.

At The Real Gut Doctor®, we evaluate complex gastrointestinal symptoms through the combined lens of conventional gastroenterology, functional medicine and precision root-cause investigation.

Our objective is not to force your symptoms into an MCAS diagnosis.

It is to determine what is actually driving them and develop the most appropriate path forward.

Schedule a Discovery Call With The Real Gut Doctor®

Stop chasing individual symptoms. Start investigating the system connecting them.

The Real Gut Doctor®
Protecting the Health That Makes Every Other Achievement Possible.

www.TheRealGutDoctor.com


About Jeffrey Mark, M.D.

Jeffrey Mark, M.D. is the founder of The Real Gut Doctor® and a board-certified gastroenterologist with more than three decades of clinical experience. His background combines conventional internal medicine and gastroenterology with advanced training in functional and regenerative medicine.

His clinical focus is the evaluation of complex gastrointestinal and systemic health problems through a precision, patient-centered approach.

Medical Review

Frances Mark, Pharm.D. provides clinical-pharmacy expertise with particular attention to medications, drug-supplement interactions, medication optimization and pharmacology.

Last medically reviewed: August 2026


Medical Disclaimer

This article is provided for educational purposes and does not constitute medical advice, diagnosis or treatment. Mast Cell Activation Syndrome is a complex disorder for which diagnostic criteria and areas of scientific debate continue to evolve. Patients with suspected anaphylaxis or severe allergic reactions require immediate medical attention. Depending on the clinical presentation, evaluation by allergy/immunology, hematology, gastroenterology or other specialists may be appropriate.

Learn more from peer-reviewed research on the U.S. National Library of Medicine (PubMed).

Picture of About Dr. Jeffrey Mark, M.D.

About Dr. Jeffrey Mark, M.D.

Dr. Jeffrey Mark, M.D. is a 5X Board-Certified Gastroenterologist and Functional Medicine expert with over 30 years of experience helping patients heal from the inside out. As the founder of The Real Gut Doctor, he blends conventional, integrative, and regenerative medicine to treat the root causes of gut issues, fatigue, inflammation, hormone imbalance, and chronic disease.

Dr. Mark’s personalized care combines nutrition, lifestyle therapy, and advanced treatments such as peptides, PRP, and exosome therapy to restore vitality and long-term wellness.

Share:
Table of Contents
Learn More

Are You Ready To Finally Feel Better?

Learning is nothing without action.
Take steps now for a better you. Call us, and we will work on it together.